# Yuan Junying

The Architect of Cell Death: Yuan Junying and China’s High-Stakes Bet on Original Innovation

Renowned biologist Yuan Junying emphasizes that China's biotech sector must transition from generic drug production to original, first-in-class discovery to survive. Her 40-year study of cell death provides a roadmap for tackling the neurodegenerative diseases of an aging population through fundamental scientific breakthroughs.